Back to Search Start Over

Coexistence of immune-mediated diseases in sarcoidosis. Frequency and clinical significance in 1737 patients

Authors :
Margarita Vives
Carles Feijoo-Massó
M. De-Vicente
M. Pérez-Conesa
Miguel López-Dupla
A.J. Chamorro
Eva Fonseca-Aizpuru
P. Perez-Guerrero
Salvador Garcia-Morillo
S. Rodríguez-Fernández
Manuel Ramos-Casals
M. Penadés
Borja de Miguel-Campo
A Alguacil
I. Ojeda
Borja Gracia-Tello
N. Toledo-Samaniego
Blanca Pinilla
E. Calvo
B. De-Escalante
G. De-la-Red
Marta Perez-de-Lis
Roberto Pérez-Alvarez
L Pallarés
Ricardo Gómez-de-la-Torre
B. de-Miguel
J. Chara-Cervantes
A. González-García
J.F. Gómez-Cerezo
M Bonet
Javier Rascón
A. Gato
Angel Robles
M. Akasbi
José Luis Callejas
E. Peral-Gutiérrez
Gracia Cruz-Caparrós
César Morcillo
Pilar Brito-Zerón
C. Soler
Source :
Joint Bone Spine. 88:105236
Publication Year :
2021
Publisher :
Elsevier BV, 2021.

Abstract

To analyze whether immune-mediated diseases (IMDs) occurs in sarcoidosis more commonly than expected in the general population, and how concomitant IMDs influence the clinical presentation of the disease.We searched for coexisting IMDs in patients included in the SARCOGEAS-cohort, a multicenter nationwide database of consecutive patients diagnosed according to the ATS/ESC/WASOG criteria. Comparisons were made considering the presence or absence of IMD clustering, and odds ratios (OR) and their 95% confidence intervals (CI) were calculated as the ratio of observed cases of every IMD in the sarcoidosis cohort to the observed cases in the general population.Among 1737 patients with sarcoidosis, 283 (16%) patients presented at least one associated IMD. These patients were more commonly female (OR: 1.98, 95% CI: 1.49-2.62) and were diagnosed with sarcoidosis at an older age (49.6 vs. 47.5years, P0.05). The frequency of IMDs in patients with sarcoidosis was nearly 2-fold higher than the frequency observed in the general population (OR: 1.64, 95% CI: 1.44-1.86). Significant associations were identified in 17 individual IMDs. In comparison with the general population, the IMDs with the strongest strength of association with sarcoidosis (OR5) were common variable immunodeficiency (CVID) (OR: 431.8), familial Mediterranean fever (OR 33.9), primary biliary cholangitis (OR: 16.57), haemolytic anemia (OR: 12.17), autoimmune hepatitis (OR: 9.01), antiphospholipid syndrome (OR: 8.70), immune thrombocytopenia (OR: 8.43), Sjögren syndrome (OR: 6.98), systemic sclerosis (OR: 5.71), ankylosing spondylitis (OR: 5.49), IgA deficiency (OR: 5.07) and psoriatic arthritis (OR: 5.06). Sex-adjusted ORs were considerably higher than crude ORs for eosinophilic digestive disease in women, and for immune thrombocytopenia, systemic sclerosis and autoimmune hepatitis in men.We found coexisting IMDs in 1 out of 6 patients with sarcoidosis. The strongest associations were found for immunodeficiencies and some systemic, rheumatic, hepatic and hematological autoimmune diseases.

Details

ISSN :
1297319X
Volume :
88
Database :
OpenAIRE
Journal :
Joint Bone Spine
Accession number :
edsair.doi.dedup.....99d9cf4793066c76395bfd23b1772923
Full Text :
https://doi.org/10.1016/j.jbspin.2021.105236